Literature DB >> 29707358

Recent progress and market analysis of anticoagulant drugs.

Ping Fan1, Yangyang Gao1, Minglin Zheng1, Ting Xu1, Paul Schoenhagen2, Zhaohui Jin1.   

Abstract

This review describes epidemiology of thromboembolic disease in China and abroad, evaluates trends in the development of anticoagulant drugs, and analyzes the market situation based on large amounts of accumulated data. Specifically, we describe advances in clinical application of anticoagulants and analyze the most commonly used anticoagulants in the market systematically.

Entities:  

Keywords:  Thromboembolic disease; anticoagulant drugs; development trend; epidemiology; market situation

Year:  2018        PMID： 29707358      PMCID： PMC5906253          DOI： 10.21037/jtd.2018.03.95

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  63 in total

1.  Treating thrombosis in the 21st century.

Authors:  Sandor S Shapiro
Journal:  N Engl J Med       Date:  2003-10-30       Impact factor: 91.245

Review 2.  Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Authors:  Cecilia Becattini; Maria Cristina Vedovati; Giancarlo Agnelli
Journal:  Thromb Res       Date:  2012-01-20       Impact factor: 3.944

3.  Exploring the isoform selectivity of TGX-221 related pyrido[1,2-a]pyrimidinone-based Class IA PI 3-kinase inhibitors: synthesis, biological evaluation and molecular modelling.

Authors:  Andrew J Marshall; Claire L Lill; Mindy Chao; Sharada V Kolekar; Woo-Jeong Lee; Elaine S Marshall; Bruce C Baguley; Peter R Shepherd; William A Denny; Jack U Flanagan; Gordon W Rewcastle
Journal:  Bioorg Med Chem       Date:  2015-04-04       Impact factor: 3.641

Review 4.  Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis.

Authors:  Claus Kroegel; Angelika Reissig
Journal:  Respiration       Date:  2003 Jan-Feb       Impact factor: 3.580

Review 5.  Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation.

Authors:  V Capra; M Bäck; D J Angiolillo; M Cattaneo; K S Sakariassen
Journal:  J Thromb Haemost       Date:  2014-02       Impact factor: 5.824

6.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

7.  Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.

Authors:  C N Berry; C Girardot; C Lecoffre; C Lunven
Journal:  Thromb Haemost       Date:  1994-09       Impact factor: 5.249

8.  Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin.

Authors:  N Sakuragawa; H Hasegawa; M Maki; M Nakagawa; M Nakashima
Journal:  Thromb Res       Date:  1993-12-15       Impact factor: 3.944

9.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.

Authors:  A Schömig; F J Neumann; A Kastrati; H Schühlen; R Blasini; M Hadamitzky; H Walter; E M Zitzmann-Roth; G Richardt; E Alt; C Schmitt; K Ulm
Journal:  N Engl J Med       Date:  1996-04-25       Impact factor: 91.245

10.  DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease.

Authors:  Stan Heptinstall; David Iyu Espinosa; Panagiotis Manolopoulos; Jackie R Glenn; Ann E White; Andrew Johnson; Natalia Dovlatova; Sue C Fox; Jane A May; David Hermann; Olafur Magnusson; Kari Stefansson; Dan Hartman; Mark Gurney
Journal:  Platelets       Date:  2008-12       Impact factor: 3.862
View more
  10 in total

1.  Rapid assembly and profiling of an anticoagulant sulfoprotein library.

Authors:  Emma E Watson; Jorge Ripoll-Rozada; Ashley C Lee; Mike C L Wu; Charlotte Franck; Tim Pasch; Bhavesh Premdjee; Jessica Sayers; Maria F Pinto; Pedro M Martins; Shaun P Jackson; Pedro José Barbosa Pereira; Richard J Payne
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-20       Impact factor: 11.205

Review 2.  Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting.

Authors:  Jiansong Huang; Xia Li; Xiaofeng Shi; Mark Zhu; Jinghan Wang; Shujuan Huang; Xin Huang; Huafeng Wang; Ling Li; Huan Deng; Yulan Zhou; Jianhua Mao; Zhangbiao Long; Zhixin Ma; Wenle Ye; Jiajia Pan; Xiaodong Xi; Jie Jin
Journal:  J Hematol Oncol       Date:  2019-03-07       Impact factor: 17.388

3.  Synthesis, characterization and anticoagulant activity of chitosan derivatives.

Authors:  Mohd Imran; Meenakshi Sajwan; Bader Alsuwayt; Mohammad Asif
Journal:  Saudi Pharm J       Date:  2019-11-12       Impact factor: 4.330

Review 4.  Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population.

Authors:  Anubhuti Saha; Ashutosh Bajpai; Vinay Krishna; Shantanu Bhattacharya
Journal:  Sensors (Basel)       Date:  2021-04-09       Impact factor: 3.576

Review 5.  Modification strategies to improve the membrane hemocompatibility in extracorporeal membrane oxygenator (ECMO).

Authors:  Ting He; Jinhui He; Zhaohui Wang; Zhaoliang Cui
Journal:  Adv Compos Hybrid Mater       Date:  2021-05-03

6.  Critical Quality Control Methods for a Novel Anticoagulant Candidate LFG-Na by HPSEC-MALLS-RID and Bioactivity Assays.

Authors:  Shunliang Zheng; Yi Wang; Jiashuo Wu; Siyao Wang; Huaifu Wei; Yongchun Zhang; Jianbo Zhou; Yue Shi
Journal:  Molecules       Date:  2022-07-15       Impact factor: 4.927

7.  Potentially Inappropriate Medication Prescribing in Older Adults According to EU(7)-Potentially Inappropriate Medication List: A Nationwide Study in Portugal.

Authors:  Daniela A Rodrigues; Ana I Plácido; Ana Bárbara Tavares; Daniela Azevedo; Ramona Mateos-Campos; Adolfo Figueiras; Maria Teresa Herdeiro; Fátima Roque
Journal:  Curr Ther Res Clin Exp       Date:  2022-07-13

Review 8.  Polymers Inspired by Heparin and Heparan Sulfate for Viral Targeting.

Authors:  Miriam Hoffmann; Nicole L Snyder; Laura Hartmann
Journal:  Macromolecules       Date:  2022-09-11       Impact factor: 6.057

Review 9.  The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology.

Authors:  Olubadewa A Fatunde; Sherry-Ann Brown
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923

10.  Impact of anticoagulation and antiplatelet drugs on surgery rates and mortality in trauma patients.

Authors:  Felix M Bläsius; Markus Laubach; Hagen Andruszkow; Cavan Lübke; Philipp Lichte; Rolf Lefering; Frank Hildebrand; Klemens Horst
Journal:  Sci Rep       Date:  2021-07-26       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.